An interventional study of Eccentric training and Conventional therapy in Hemiparesis;Poststroke/CVA, sponsored by Clinique Du Parc de Belleville. Recruiting at 1 site in France. Open to participants aged 20 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-20.
Sponsored by Clinique Du Parc de Belleville · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Paresis with a site in France — 12 open to participants now, 12 under way, none of them phase 3. Paresis · France.
Among the 26 studies in Paresis with a site in France, this one is the 10th largest by planned enrollment of the 22 interventional ones that give a count, is one of 4 that started in 2023, is one of 22 with no phase, reaches primary completion later than 1 of the 11 other live ones, and was the 19th registered.
473 studies on the registry are indexed under Paresis; 121 are open to participants now.
Browse Paresis studies →12 of the 26 studies in Paresis with a site in France are open now. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Rennes University Hospital · Sites in France
Ages 18–75
Wandercraft · Sites in France, Germany, Spain
Ages 18+
Institut National de la Santé Et de la Recherche Médicale, France · Sites in France
Ages 18–70
Neuroloco · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 84 Paresis studies recruiting now, 34 (40%) set no upper age limit and 27 (32%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 20 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 4 started in 2023.
This study's planned enrollment of 40 is above the median of 36 across 425 interventional studies indexed under Paresis.
Median enrollment 40 across the 22 interventional studies, 75 across the 4 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 26 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Clinique Du Parc de Belleville as lead sponsor.
Clinique Du Parc de Belleville has 1 study filed under Paresis — fewer than ten, so there is no comparison to draw.
3 of the studies in Paresis with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07082036Assistance Publique - Hôpitaux de ParisStability of Hemiparetic Patients During a Daily Complex Task | 2026-11 |
| NCT05277519Institut National de la Santé Et de la Recherche Médicale, FranceNeuroplasticity After Proprioceptive Rehabiliation | 2027-06-15 |
| NCT04119544Clinique Les Trois SoleilsMirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2) | 2027-07-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 26 studies in Paresis with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to compare between Eccentric training and conventional therapy in sub-acute stroke survivors. The primary objective of this study is to evaluate improvements in gait speed after four months of ET in comparison to conventional therapy for patients with sub-acute stroke. Secondary objectives involve assessing: i) modifications in neuromuscular parameters of PF, ii) changes in muscle stiffness within PF during passive mobilization and active force generation, and iii) modifications in architectural parameters of PF.
This study will be a single-blinded, controlled, randomized design, wherein participants will be randomly assigned to one of two groups: the Conventional Therapy Group (CTG) or the Eccentric Training Group (ETG). Both groups will undergo a comprehensive series of assessments at three key time points: Ji (initial assessment), Jint (intermediate assessment), and Jf (final assessment). The study will commence with a recruitment phase, followed by a screening phase. Subsequently, there will be a 4-week period allocated for experimental testing before the intervention, and an additional 4 weeks for experimental testing after the intervention. These assessments will encompass a wide range of evaluations, including clinical health assessments, biomechanical assessments, neuromuscular evaluations, and functional assessments
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In conventional therapy, the treatment plan is determined based on medical opinion. After admission, each patient undergoes several multidisciplinary assessments aimed at objectively determining the care based on their needs. In this group, patients received only conventional rehabilitation. This will carry out in the same manner as a regular practice of the clinic. 3 sessions per week
Procedure: Conventional therapy
In the absence of a standardized eccentric isokinetic training protocol established for hemiparetic subjects on the plantar flexor muscles, the protocol designed for this study drew inspiration from the one established by Clark and Patten. (2013) and by Harris-Love et al. (2017).This protocol allows the introduction of an eccentric stimulus for individuals who are new to this type of training and progressively advances their program to include workload levels sufficiently to stimulate muscle plasticity optimally, thereby inducing skeletal muscle adaptations. 3 sessions per week
Procedure: Eccentric training · Procedure: Conventional therapy
The eccentric program will last for 16 weeks, with a frequency of 2 sessions per week, totalling 32 sessions. At least 1 day of rest will be required between two training sessions. The participants will be placed in the similar position of the neuromuscular assessments (reference position). The Biodex System 4 dynamometer settings for the exercise sessions were also like the settings used for the assessments. The training program will be divided into two phases: a familiarization phase and a progression phase
3 sessions per week of physical therapy with musculotendinous stretching and balance rehabilitation
gait speed (m/s) through the 10-meter walking test.
An analysis of the walking pattern will be conducted to quantify the evolution of spatio-temporal and barometric parameters of walking and their asymmetry.
Time frame: initial assessment in the first week of the inclusion, intermediate assessment at 6 weeks of the inclusion, and final assessment at 12 weeks of the inclusion
Biomechanical proprieties
muscle stiffness, as expressed by the shear modulus (µ, in Kpa), will be assessed during passive ankle joint mobilization from dorsiflexion to plantar flexion and during maximal voluntary isometric contraction of Plantar flexors
Time frame: initial assessment in the first week of the inclusion, intermediate assessment at 6 weeks of the inclusion, and final assessment at 12 weeks of the inclusion
Structural parameters
Fascicle length and thickness (mm) will be assessed using the ultrasound scanner.
Time frame: initial assessment in the first week of the inclusion, intermediate assessment at 6 weeks of the inclusion, and final assessment at 12 weeks of the inclusion
Neuromuscular parameters
Peak force (N/m), submaximal force (N/m) and rate of force development (N/m) will be evaluated using the BIODEX isokinetic device during maximal volontary contraction
Time frame: initial assessment in the first week of the inclusion, intermediate assessment at 6 weeks of the inclusion, and final assessment at 12 weeks of the inclusion
Functional parameters
maximal range of motion (deg/s) , defined as the extent of stretch that the participant can comfortably endure during the stretching maneuver, will be measured using the BIODEX isokinetic device
Time frame: initial assessment in the first week of the inclusion, intermediate assessment at 6 weeks of the inclusion, and final assessment at 12 weeks of the inclusion
Plan to share: No — Data will be shared upon request from researchers
No publications or documents are linked to this record.
Start is estimated for Dec 2023; primary completion for Jun 2024, 6 months later.
Of 223 non-industry interventional studies with no phase under Paresis, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 55. This study's planned 6 months is below that.
Counting every sponsor, half of 241 studies reached it within 32 months; a quarter within 13 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.